Filing Flows › Companies › Privia Health Group › Timeline
Privia Health Group stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions+1.9% to $24.42
Privia Health Group (PRVA) stock rose 2% over the last 252 sessions, to $24.42. On the way it reported 5 quarters, its insiders filed 12 open-market trades and 3 Form 144 notices of planned sales, and the company filed 2 material 8-Ks. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Nov 5, 2026 | Earnings | Earnings: missed the EPS estimate by -11.8% | +6.7% (+11.2% vs SPY) | — | — |
| Aug 18, 2026 | 8-K | Directors and officers: departures, appointments, pay | +0.1% (+0.8% vs SPY) | −2.3% (−1.1% vs SPY) | −5.4% (−3.0% vs SPY) |
| Aug 6, 2026 | Earnings | Earnings: missed the EPS estimate by -22.2% | −8.5% (−8.4% vs SPY) | −10.7% (−11.0% vs SPY) | −14.8% (−15.2% vs SPY) |
| Jul 9, 2026 | Form 144 | Form 144: David Mountcastle plans to sell $589K | +2.0% (+1.2% vs SPY) | +3.2% (+2.0% vs SPY) | −21.2% (−24.3% vs SPY) |
| Jul 7, 2026 | 8-K | Directors and officers: departures, appointments, pay | −0.1% (+0.2% vs SPY) | +2.9% (+2.4% vs SPY) | −12.8% (−15.7% vs SPY) |
| Jul 2, 2026 | Form 144 | Form 144: David Mountcastle plans to sell $680K | +1.8% (+1.9% vs SPY) | +3.3% (+2.5% vs SPY) | −12.7% (−12.9% vs SPY) |
| Jun 26, 2026 | Form 144 | Form 144: David Mountcastle plans to sell $433K | +4.2% (+4.9% vs SPY) | +10.9% (+9.5% vs SPY) | +0.6% (−0.1% vs SPY) |
| May 11, 2026 | Insider sale | Mountcastle David sold $77K | −1.3% (−1.5% vs SPY) | −0.5% (−0.7% vs SPY) | −3.9% (−3.9% vs SPY) |
| May 7, 2026 | Earnings | Earnings: missed the EPS estimate by -24.1% | 0.0% (+0.3% vs SPY) | −5.8% (−7.0% vs SPY) | −10.4% (−10.9% vs SPY) |
| Apr 2, 2026 | Insider sale | Mountcastle David sold $116K | +0.7% (+0.6% vs SPY) | +7.5% (+3.8% vs SPY) | +16.5% (+7.0% vs SPY) |
| Mar 16, 2026 | Insider sale | Mountcastle David sold $141K | +1.3% (+0.3% vs SPY) | −2.0% (−0.2% vs SPY) | +6.4% (+1.4% vs SPY) |
| Mar 16, 2026 | Insider sale | Mehrotra Parth sold $586K | +1.3% (+0.3% vs SPY) | −2.0% (−0.2% vs SPY) | +6.4% (+1.4% vs SPY) |
| Mar 13, 2026 | Insider sale | Mountcastle David sold $141K | −0.2% (+0.3% vs SPY) | +0.2% (+1.1% vs SPY) | +5.7% (+2.5% vs SPY) |
| Mar 13, 2026 | Insider sale | Mehrotra Parth sold $586K | −0.2% (+0.3% vs SPY) | +0.2% (+1.1% vs SPY) | +5.7% (+2.5% vs SPY) |
| Mar 12, 2026 | Insider sale | Mountcastle David sold $141K | −1.6% (0.0% vs SPY) | −2.2% (0.0% vs SPY) | +1.3% (+0.6% vs SPY) |
| Mar 12, 2026 | Insider sale | Mehrotra Parth sold $586K | −1.6% (0.0% vs SPY) | −2.2% (0.0% vs SPY) | +1.3% (+0.6% vs SPY) |
| Mar 9, 2026 | Insider sale | Mountcastle David sold $133K | +0.1% (−0.7% vs SPY) | −7.1% (−5.6% vs SPY) | −3.9% (−2.2% vs SPY) |
| Mar 9, 2026 | Insider sale | Fargis Edward C sold $113K | +0.1% (−0.7% vs SPY) | −7.1% (−5.6% vs SPY) | −3.9% (−2.2% vs SPY) |
| Mar 6, 2026 | Insider sale | Mountcastle David sold $120K | −2.4% (−1.1% vs SPY) | −9.3% (−7.0% vs SPY) | −9.9% (−6.8% vs SPY) |
| Mar 6, 2026 | Insider sale | Fargis Edward C sold $102K | −2.4% (−1.1% vs SPY) | −9.3% (−7.0% vs SPY) | −9.9% (−6.8% vs SPY) |
| Feb 26, 2026 | Earnings | Earnings: beat the EPS estimate by 30.2% | +9.5% (+10.1% vs SPY) | +7.0% (+8.2% vs SPY) | −11.5% (−4.6% vs SPY) |
| Nov 6, 2025 | Earnings | Earnings: beat the EPS estimate by 33.7% | −4.2% (−3.2% vs SPY) | −3.3% (−4.1% vs SPY) | −4.8% (−6.0% vs SPY) |
Insiders’ record here
In the year on the chart, Privia Health Group's insiders reported 0 open-market buys ($0) and 12 sales ($2.8M). Of the 12 old enough to score, 11 were followed by the stock doing what the trade implied over the next 63 sessions (beating SPY after a buy, lagging it after a sale); the median excess return after a buy was — and after a sale −7.7%.
Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 5.02 Directors and officers: departures, appointments, pay | 39,174 | −0.1% | 48% | +0.7% | ±1.4% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
Report card: every quarter against the estimate → Privia Health Group: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.